Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease

NCT01696396 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
254
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen